Today: 10 lutego 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3t-pl- Page 139

Pfizer (PFE) Stock on December 6, 2025: Metsera Deal, 2025 Guidance and What Wall Street Expects Next

Pfizer (PFE) Stock on December 6, 2025: Metsera Deal, 2025 Guidance and What Wall Street Expects Next

Pfizer shares closed at $26.03 on December 5, 2025, up 1.28% and 24% above April’s low. The stock yields about 6.6% with an annualized dividend of $1.72 per share and has paid 347 consecutive quarterly dividends. Pfizer’s Q3 revenue fell 6% to $16.65 billion, but adjusted EPS beat expectations at $0.87. The stock trades at 8–9x forward earnings, below the market average.
6 grudnia 2025
···
Gorilla Technology Group (GRRR) Stock: CVR Payout, Nobel Sustainability Nomination and a $1.4 Billion AI Bet – What Investors Need to Know Now

Gorilla Technology Group (GRRR) Stock: CVR Payout, Nobel Sustainability Nomination and a $1.4 Billion AI Bet – What Investors Need to Know Now

Gorilla Technology (NASDAQ: GRRR) closed at $14.97 on Dec. 5, 2025, with a market cap near $350–430 million and short interest at 12%. The company secured a $1.4 billion AI data-center contract in Southeast Asia and reported record revenue, but posted a $67 million net loss over the past year. GRRR shares are up over 150% in 12 months but down 20–25% in the past six months. Analyst opinions remain sharply split.
6 grudnia 2025
·
Gilead Sciences Stock (GILD) Outlook 2026: Latest News, Trodelvy Data, Dividend and Analyst Forecasts

Gilead Sciences Stock (GILD) Outlook 2026: Latest News, Trodelvy Data, Dividend and Analyst Forecasts

Gilead Sciences shares closed at $121.22 on December 5, 2025, about 6% below their 52-week high. Third-quarter revenue rose 3% year-over-year to $7.8 billion, with HIV product sales up 4% to $5.3 billion. Veklury sales dropped as COVID cases fell. The company continues to invest in oncology and cell therapy despite near-term earnings pressure.
6 grudnia 2025
···
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth shares closed at $1.15 on December 5, down 4.96%, but remain up about 13–14% over the last 10 sessions. Q2 FY2026 net revenue rose 6% to C$66.7 million, with gross margin improving to 33%. Net loss narrowed sharply to C$1.6 million from C$131.6 million a year earlier. The company ended the quarter with C$298 million in cash, exceeding its total debt.
6 grudnia 2025
··
SPDR Gold Trust (GLD) Surges 60% in 2025: Latest News, Fed Cut Bets and 2026 Gold Price Forecast

SPDR Gold Trust (GLD) Surges 60% in 2025: Latest News, Fed Cut Bets and 2026 Gold Price Forecast

SPDR Gold Shares (GLD) closed at $386.44 on December 5, down 0.2%, with assets over $140 billion and a net asset value of $390.26 per share. GLD has surged 59.6% year-to-date, outpacing the S&P 500, and posted a one-year Sharpe ratio of 3.07. The ETF tracks physical gold and does not pay dividends. Investors are watching the upcoming Federal Reserve meeting and gold price forecasts.
6 grudnia 2025
··
Tilray Brands (TLRY) Stock in December 2025: Reverse Split, 90% Rally and What the Latest Forecasts Really Say

Tilray Brands (TLRY) Stock in December 2025: Reverse Split, 90% Rally and What the Latest Forecasts Really Say

Tilray Brands executed a 1-for-10 reverse stock split effective December 2, reducing outstanding shares from 1.16 billion to 116 million. Shares dropped over 20% after the split was scheduled, deepening year-to-date losses, but the stock remains up 90% over six months. Trading volume surged post-split. Analysts cite optimism over U.S. cannabis policy and Tilray’s first profit, but warn of regulatory risks.
7 grudnia 2025
·
Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk shares have dropped about 45% in 2025 and over 50% from their 2024 peak, following profit warnings, slower GLP-1 growth, and a failed Alzheimer’s trial. The stock now trades near $47.9, down sharply after the EVOKE and EVOKE+ studies showed no significant benefit for semaglutide in early Alzheimer’s. Revenue in Q3 2025 rose 5% to DKK 74.98 billion, missing analyst expectations.
7 grudnia 2025
··
TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally?

TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally?

Direxion Daily TSLA Bull 2X Shares ETF (TSLL) surged about 30% in two weeks, trading near $20.60 as of December 7, 2025, with gains in 8 of the last 10 sessions. Despite the rally, TSLL remains down roughly 30% year-to-date and far below its 52-week high of $40.57. Assets under management stand near $7 billion, with average daily volume around 134 million shares.
7 grudnia 2025
···
Axon Stock (AXON) Today: Price, Forecasts and AI Policing Risks – December 7, 2025

Axon Stock (AXON) Today: Price, Forecasts and AI Policing Risks – December 7, 2025

Axon shares closed at $550.95 on December 6, 2025, down 38% from their August high of $885.92 and 31% over six months. The company, now valued at about $43 billion, faces scrutiny over its AI policing tools and a facial-recognition body-camera trial in Canada. Wall Street price targets average $800–815. Short interest remains modest at 2–3% of free float.
7 grudnia 2025
··
KBIZ, Greater New York Chamber and KACCUSA Unite to Fast‑Track Korean SMEs’ U.S. Market Expansion

KBIZ, Greater New York Chamber and KACCUSA Unite to Fast‑Track Korean SMEs’ U.S. Market Expansion

The Korea Federation of SMEs signed an MOU with the Greater New York Chamber of Commerce on December 5, aiming to help Korean small and medium-sized businesses enter the New York market. Senior leaders from both organizations and Korean-American business groups attended the ceremony in Seoul. The agreement focuses on buyer discovery, networking, and sharing market intelligence.
7 grudnia 2025
UK ‘Two‑Tier State Pension’ Row: What Rachel Reeves’ Autumn Budget 2025 Means for Your Taxes and Retirement

UK ‘Two‑Tier State Pension’ Row: What Rachel Reeves’ Autumn Budget 2025 Means for Your Taxes and Retirement

Chancellor Rachel Reeves confirmed pensioners with only state pension income will not pay income tax during this Parliament, following the Autumn Budget 2025. Retirees with any additional income, such as a private pension, will still be taxed. The policy has drawn criticism for creating a “two-tier state pension.” The full new state pension will rise 4.8% to £241.30 per week from April 2026.
7 grudnia 2025
·
Best Semiconductor Stocks to Buy Now (December 7, 2025) – 10 Chip Leaders for the AI Supercycle

Best Semiconductor Stocks to Buy Now (December 7, 2025) – 10 Chip Leaders for the AI Supercycle

Global chip sales are projected to rise 22–23% in 2025 to $772 billion and over 26% in 2026 to $975 billion, according to WSTS. Logic and memory chips are forecast to grow more than 30% in 2026. Asia-Pacific and the Americas are leading regional growth. Nvidia reported $57 billion in fiscal Q3 revenue and maintains over 90% of the data center GPU market.
7 grudnia 2025
··
Best Microsoft Surface Pro 11 & Laptop 7 Deals Now (December 7, 2025): Up to $850 Off Copilot+ PCs

Best Microsoft Surface Pro 11 & Laptop 7 Deals Now (December 7, 2025): Up to $850 Off Copilot+ PCs

B&H Photo’s December 4 flash sale cut up to $850 off Microsoft Copilot+ PCs, dropping the Surface Pro 11 and Surface Laptop 7 to $1,249.99. The one-day event ended, but retailers including B&H, Amazon, and Microsoft Store continue to offer smaller discounts on the same models. Coverage from CNET, 9to5Toys, and others amplified the deals, with some “last chance” offers still active as of December 7.
7 grudnia 2025
·
Gorilla Technology (GRRR) Stock on December 7, 2025: Latest News, CVR Shake-Up, Forecasts and Analyst Outlook

Gorilla Technology (GRRR) Stock on December 7, 2025: Latest News, CVR Shake-Up, Forecasts and Analyst Outlook

Gorilla Technology (NASDAQ: GRRR) closed at $14.97 on December 5, down 3.36%, with after-hours trading at $15.03 and a market cap near $430 million. Q3 revenue reached a record $26.5 million, up 32% year-on-year. The company reported a $1.4 billion AI data-center mandate and a $7 billion pipeline. Analyst price targets vary widely, from $18 to $39.
7 grudnia 2025
·
Mastercard (MA) Stock Outlook December 2025: Earnings Beat, AI ‘Agent Pay’, Swipe‑Fee Deal and 2026 Forecasts

Mastercard (MA) Stock Outlook December 2025: Earnings Beat, AI ‘Agent Pay’, Swipe‑Fee Deal and 2026 Forecasts

Mastercard opened near $545 per share on December 7, 2025, with a market cap of about $490 billion and a trailing P/E around 35. Q3 earnings showed adjusted EPS of $4.38, beating estimates, and net revenue up in the mid-teens percent year over year. The company’s quarterly dividend stands at $0.76 per share. Shares remain about 9% below their 52-week high.
7 grudnia 2025
··
Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Medtronic shares closed at $101.36 on Dec. 5, 2025, up 18.8% over the past year and outpacing the S&P 500. The company reported strong fiscal Q2 results, raised guidance, and announced new FDA clearances for its Hugo surgical robot and Altaviva device. Elliott Investment Management became a top shareholder, prompting board changes and a planned Diabetes business spin-off. Dividend yield stands at about 2.8%.
7 grudnia 2025
·
Wayfair (W) Stock: 2025 Rally, Jefferies Downgrade and New Wall Street Forecasts – Latest News as of December 7, 2025

Wayfair (W) Stock: 2025 Rally, Jefferies Downgrade and New Wall Street Forecasts – Latest News as of December 7, 2025

Wayfair shares closed at $95.21 on December 5, 2025, up over 140% year-to-date, with a market cap near $12.3 billion. Jefferies downgraded the stock to “Hold” this week, citing weak holiday demand and stretched valuation, sending shares down 5.7% intraday. Insider selling has increased, but most analysts still rate the stock a “Moderate Buy.” Consensus price target stands at $105.29.
7 grudnia 2025
·
Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical shares closed at $575.34 on December 5, up 1.18%, near the top of their 52-week range. CalPERS raised its stake by 7% in Q2, while Executive Chair Gary Guthart sold $13 million in stock on December 1. Trading volume was light, but ISRG outperformed medtech peers. Some analysts describe the stock’s technical outlook as neutral.
7 grudnia 2025
·
1 … 137 138 139 140 141 … 172
Go toTop